First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Share Price, News & Analysis

Company Overview

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content. The company operates under the brand name of Blackbird. The company was founded in 1998 and is based in London, the United Kingdom.

Key Stats

• Today's Range: 1,638.72 to 1,638.72
• 50-Day Range: 1,553.40 to 1,698.30
• 52-Week Range: 1,388 to 1,698.30
• Volume: 21 shs
• Average Volume: 1,655 shs
• Market Capitalization: £4.84 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FBT Stock Analysis - Frequently Asked Questions

How have FBT shares performed this year?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's stock was trading at GBX 1,625.60 at the start of the year. Since then, FBT stock has increased by 0.8% and is now trading at GBX 1,638.72.
View the best growth stocks for 2025 here.

How do I buy shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation?

Shares of FBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation own?

Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation investors own include Taylor Wimpey (TW), ARK Genomic Revolution ETF (ARKG), Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ), ARK Innovation ETF (ARKK), Barrick Gold (GOLD) and Intel (INTC).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Computer and Technology
• Industry: Software - Application
• Sub-Industry: N/A
• Current Symbol: LON:FBT
• CUSIP: N/A
• CIK: N/A
• Web: www.forbidden.co.uk
• Phone: +44-20-88797245
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.04
• Current Ratio: 9.42
• Quick Ratio: 9.27

Sales & Book Value

• Annual Sales: £870,310.00
• Price / Sales: 5,563.74
• Cash Flow: GBX 462.38 per share
• Price / Cash Flow: 3.54
• Book Value: GBX 1.90 per share
• Price / Book: 862.48

Miscellaneous

• Outstanding Shares: 295,486,016
• Free Float: N/A
• Market Cap: £4.84 billion
• Optionable: Not Optionable
• Beta: N/A